AIM:To observe the synergistic effects of hyperthermia in oxaliplatin-induced cytotoxicity in human colon adenocarcinoma Lovo cells.METHODS:The human colon adenocarcinoma cell line Lovo was obtained from Sun Yat-Sen U...AIM:To observe the synergistic effects of hyperthermia in oxaliplatin-induced cytotoxicity in human colon adenocarcinoma Lovo cells.METHODS:The human colon adenocarcinoma cell line Lovo was obtained from Sun Yat-Sen University.Cells were sealed with parafilm and placed in a circulating water bath,and was maintained within 0.01 ℃ of the desired temperature (37 ℃,39 ℃,41 ℃,43 ℃ and 45 ℃).Thermal therapy was given alone to the negative control group while oxaliplatin was administered to the treatment group at doses of 12.5 μg/mL and 50 μg/mL.Identification of morphological changes,3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide assay,flow cytometry and Western blotting were used to investigate the effect of thermochemotherapy on human colon adenocarcinoma Lovo cells,including changes in the signal pathway related to apoptosis.RESULTS:A temperature-dependent inhibition of cell growth was observed after oxaliplatin exposure,while a synergistic interaction was detected preferentially with sequential combination.Thermochemotherapy changed the morphology of Lovo cells,increased the inhibition rate of the Lovo cells (P < 0.05) and enhanced cellular population in the G 0 /G 1 phase (16.7% ± 4.8 % in phase S plus 3.7% ± 2.4 % in phase G 2 /M,P < 0.05).Thermochemotherapy increased apoptosis through upregulating p53,Bax and downregulating Bcl-2.Protein levels were elevated in p53,Bax/Bcl-2 in thermochemotherapy group as compared with the control group (P < 0.05).CONCLUSION:Thermochemotherapy may play an important role in apoptosis via the activation of p53,Bax and the repression of Bcl-2 in Lovo cells.展开更多
Primary myelofibrosis(PMF) is a clonal hematopoietic stem cell disorder. It is characterized by bone marrow fibrosis, extramedullary hematopoiesis with hepatosplenomegaly and leukoerythroblastosis in the peripheral bl...Primary myelofibrosis(PMF) is a clonal hematopoietic stem cell disorder. It is characterized by bone marrow fibrosis, extramedullary hematopoiesis with hepatosplenomegaly and leukoerythroblastosis in the peripheral blood. The main clinical manifestations of PMF are anemia, bleeding, hepatosplenomegaly, fatigue, and fever. Here we report a rare case of PMF with anemia, small bowel obstruction and ascites due to extramedullary hematopoiesis and portal hypertension. The diagnosis was difficult to establish before surgery and the differential diagnosis is discussed.展开更多
基金Supported by The Guangdong Provincial Science and Technology Programs,China,No.2009A030301013the Scientific Funds of Guangzhou Medical College,China,No.2010A29+1 种基金National Natural Science Foundation of China,No.30700398 and 81172831Natural Science Foundation of Guangdong Province,No.10151008901000200
文摘AIM:To observe the synergistic effects of hyperthermia in oxaliplatin-induced cytotoxicity in human colon adenocarcinoma Lovo cells.METHODS:The human colon adenocarcinoma cell line Lovo was obtained from Sun Yat-Sen University.Cells were sealed with parafilm and placed in a circulating water bath,and was maintained within 0.01 ℃ of the desired temperature (37 ℃,39 ℃,41 ℃,43 ℃ and 45 ℃).Thermal therapy was given alone to the negative control group while oxaliplatin was administered to the treatment group at doses of 12.5 μg/mL and 50 μg/mL.Identification of morphological changes,3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide assay,flow cytometry and Western blotting were used to investigate the effect of thermochemotherapy on human colon adenocarcinoma Lovo cells,including changes in the signal pathway related to apoptosis.RESULTS:A temperature-dependent inhibition of cell growth was observed after oxaliplatin exposure,while a synergistic interaction was detected preferentially with sequential combination.Thermochemotherapy changed the morphology of Lovo cells,increased the inhibition rate of the Lovo cells (P < 0.05) and enhanced cellular population in the G 0 /G 1 phase (16.7% ± 4.8 % in phase S plus 3.7% ± 2.4 % in phase G 2 /M,P < 0.05).Thermochemotherapy increased apoptosis through upregulating p53,Bax and downregulating Bcl-2.Protein levels were elevated in p53,Bax/Bcl-2 in thermochemotherapy group as compared with the control group (P < 0.05).CONCLUSION:Thermochemotherapy may play an important role in apoptosis via the activation of p53,Bax and the repression of Bcl-2 in Lovo cells.
基金Supported by National Natural Science Foundation of China,No.81272640Guangdong Science and Technology Program,No.2010B031200008 and No.2012B031800043
文摘Primary myelofibrosis(PMF) is a clonal hematopoietic stem cell disorder. It is characterized by bone marrow fibrosis, extramedullary hematopoiesis with hepatosplenomegaly and leukoerythroblastosis in the peripheral blood. The main clinical manifestations of PMF are anemia, bleeding, hepatosplenomegaly, fatigue, and fever. Here we report a rare case of PMF with anemia, small bowel obstruction and ascites due to extramedullary hematopoiesis and portal hypertension. The diagnosis was difficult to establish before surgery and the differential diagnosis is discussed.
